LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹5.29 Cr | ₹1.95 Cr | ₹-22 Cr | ₹-63 Cr | ₹-12 Cr |
What is the latest Cash Flow from Financing Activities ratio of LYKA LABS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹5.29 Cr |
Mar2024 | ₹1.95 Cr |
Mar2023 | ₹-22 Cr |
Mar2022 | ₹-63 Cr |
Mar2021 | ₹-12 Cr |
How is Cash Flow from Financing Activities of LYKA LABS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹5.29 Cr | 170.97 | |
Mar2024 | ₹1.95 Cr | Positive | |
Mar2023 | ₹-22 Cr | Negative | |
Mar2022 | ₹-63 Cr | Negative | |
Mar2021 | ₹-12 Cr | - |
Compare Cash Flow from Financing Activities of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹355.4 Cr | -0.2% | -10.2% | -34.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,594.0 Cr | -3.3% | -6.9% | -9.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,722.0 Cr | 1.7% | -6.8% | 25.4% | Stock Analytics | |
CIPLA | ₹127,508.0 Cr | -0.9% | 0.5% | -0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,111.0 Cr | -1.9% | -1.3% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,225.0 Cr | -1.2% | -2% | -9% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | -0.2% |
-10.2% |
-34.9% |
SENSEX | -2.2% |
-1.7% |
-1.2% |
You may also like the below Video Courses